Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial
Centre Hospitalier Universitaire de Lille · Inserm · +24 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
870
total citations
- FWCI
- 40.50
- Percentile
- 100%
- References
- 35
Citations per year
Authors
27- TFThierry FaçonCorresponding
Centre Hospitalier Universitaire de Lille
- JYJean Yves Mary
Inserm, Hôpital Saint-Louis, Université Paris Cité
- CHCyrille Hulin
Centre Hospitalier Régional et Universitaire de Nancy
- LBLotfi Benboubker
Centre Hospitalier Universitaire de Tours
- MAMichel Attal
Centre Hospitalier Universitaire de Toulouse
Topics & keywords
Topics
Keywords
- Melphalan
- Medicine
- Prednisone
- Thalidomide
- Multiple myeloma
- Autologous stem-cell transplantation
- Transplantation
- Surgery
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.